ARCH Venture Fund VIII, L.P.

Entity
Company
Business address
8755 W. Higgins Road, Suite 1025, 60631 Chicago, IL
Phone
776-380-6600
State of incorporation
DE
Fiscal year end
December 31
Signature Ownership
ARCH Venture Fund VIII, L.P. By: ARCH Venture Partners VIII, L.P., its General Partner By: ARCH Venture Partners VIII, LLC, its General Partner By: /s/ Mark McDonnell, as Attorney-in-Fact for Keith Crandell, Managing Director
All SEC filings
View on sec.gov
Get insider transactions for this reporting owner
ARCH Venture Fund VIII, L.P. has filed 38 SEC EDGAR filings since 4/24/2014

Latest Filings

Form type Document Filing Description Filing date Reporting date File number(s)
SC 13G/A Open Document Open Filing ARCH VENTURE FUND VIII, L.P. - HOMOLOGY MEDICINES, INC. -- SCH 13G/A(#2E) May 13, 2024
SC 13G/A Open Document Open Filing ARCH VENTURE FUND VIII, L.P. - SCHOLAR ROCK HOLDING CORP -- SCH 13G/A(#2E) Feb 14, 2024
SC 13D Open Document Open Filing ARCH VENTURE FUND VIII, L.P. -- CODIAK BIOSCIENCES, INC. -- SCHEDULE 13D Sep 20, 2022
4 Open Document Open Filing STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES Sep 15, 2022 Sep 13, 2022 001-39615
SC 13G/A Open Document Open Filing ARCH VENTURE FUND VIII, L.P. - DENALI THERAPEUTICS INC. -- SCH 13G/A (#3E) Feb 8, 2022
SC 13G Open Document Open Filing ARCH VENTURE FUND VIII, L.P. - CODIAK BIOSCIENCES, INC. -- SCH 13G Feb 4, 2021
SC 13G Open Document Open Filing ARCH VENTURE FUND VIII, L.P. - METACRINE, INC. -- SCH 13G Feb 2, 2021
SC 13G/A Open Document Open Filing ARCH VENTURE FUND VIII, L.P. - DENALI THERAPEUTICS INC. -- SCH 13G/A (#2) Feb 2, 2021
4 Open Document Open Filing FORM 4 SUBMISSION Oct 20, 2020 Oct 16, 2020 001-39615
3 Open Document Open Filing FORM 3 SUBMISSION Oct 13, 2020 Oct 13, 2020 001-39615
4 Open Document Open Filing FORM 4 SUBMISSION Sep 22, 2020 Sep 18, 2020 001-39512
3 Open Document Open Filing FORM 3 SUBMISSION Sep 15, 2020 Sep 15, 2020 001-39512
SC 13G/A Open Document Open Filing ARCH VENTURE FUND VIII, L.P. - SCHOLAR ROCK HOLDING CORPORATION -- SCHEDULE 13G/ Feb 13, 2020
SC 13G/A Open Document Open Filing ARCH VENTURE FUND VIII, L.P. - DENALI THERAPEUTICS INC. -- SCHEDULE 13G/A(#1) Feb 13, 2020
SC 13G/A Open Document Open Filing ARCH VENTURE FUND VIII, L.P. - HOMOLOGY MEDICINES, INC. -- SCHEDULE 13G/A(#1) Feb 13, 2020
4 Open Document Open Filing PRIMARY DOCUMENT Aug 12, 2019 Aug 8, 2019 001-38311
4 Open Document Open Filing PRIMARY DOCUMENT May 23, 2019 May 21, 2019 001-38433
SC 13D Open Document Open Filing ARCH VENTURE FUND VIII, L.P. - SIENNA BIOPHARMACEUTICALS -- SCHEDULE 13D Mar 6, 2019
4 Open Document Open Filing PRIMARY DOCUMENT Feb 26, 2019 Feb 22, 2019 001-38155
SC 13G/A Open Document Open Filing ARCH VENTURE FUND VIII, L.P. - SIENNA BIOPHARMACEUTICALS, INC. -- SCHEDULE 13G/A Feb 14, 2019
SC 13G Open Document Open Filing ARCH VENTURE FUND VIII, L.P. - SCHOLAR ROCK HOLDING CORP -- SCHEDULE 13G Feb 14, 2019
SC 13G/A Open Document Open Filing ARCH VENTURE FUND VIII, L.P. - KURA ONCOLOGY, INC. -- SCHEDULE 13G/A(#3) Feb 14, 2019
SC 13G Open Document Open Filing ARCH VENTURE FUND VIII, L.P. - HOMOLOGY MEDICINES, INC. -- SCHEDULE 13G Feb 14, 2019
4 Open Document Open Filing 4 May 31, 2018 May 29, 2018 001-38501
3 Open Document Open Filing 3 May 23, 2018 May 23, 2018 001-38501
4 Open Document Open Filing FORM 4 SUBMISSION Apr 4, 2018 Apr 2, 2018 001-38433
3 Open Document Open Filing FORM 3 SUBMISSION Mar 27, 2018 Mar 27, 2018 001-38433
SC 13G Open Document Open Filing ARCH VIII - SIENNA BIOPHARMACEUTICALS, INC. 13G Feb 2, 2018
SC 13G Open Document Open Filing ARCH VIII - DENALI THERAPEUTICS INC. 13G Feb 2, 2018
4 Open Document Open Filing FORM 4 SUBMISSION Dec 12, 2017 Dec 12, 2017 001-38311
3 Open Document Open Filing FORM 3 SUBMISSION Dec 7, 2017 Dec 7, 2017 001-38311
4 Open Document Open Filing FORM 4 Aug 1, 2017 Aug 1, 2017 001-38155
3 Open Document Open Filing FORM 3 Jul 26, 2017 Jul 26, 2017 001-38155
SC 13G/A Open Document Open Filing KURA ONCOLOGY, INC. -- SCHEDULE 13G (AMEND. #2) Feb 13, 2017
SC 13G/A Open Document Open Filing KURA ONCOLOGY - AMEND. #1 Feb 16, 2016
SC 13G Open Document Open Filing KURA ONCOLOGY Mar 13, 2015
D/A Open Document Open Filing Aug 27, 2014 021-216149
D Open Document Open Filing Apr 24, 2014 021-216149